Dr. Anita Mehrotra, MD

Dr. Mehrotra practices at Virtua Home Care at West Jersey in Marlton, New Jersey.

Dr. Mehrotra's NPI, 1407065386, was assigned on May 21, 2007. Dr. Mehrotra graduated from Jefferson Medical College of Thomas Jefferson University in 2004. Dr. Mehrotra holds New Jersey license 25MA10198200.

Dr. Mehrotra's primary practice is Virtua Home Care at West Jersey, at 301 Lippincott Drive - 2nd Floor, Marlton, NJ 08053. The practice phone is (856) 581-7200.

Dr. Mehrotra's primary practice is Virtua Home Care at West Jersey in Marlton, New Jersey. Dr. Mehrotra is also affiliated with Virtua Voorhees Hospital. The medical group on file is Virtua Medical Group. Dmand AI also links Dr. Mehrotra to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Mehrotra's employer is on file too: a home health agency.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehrotra practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Mehrotra's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Mehrotra's licenses on file in 2 states: New Jersey and New York.

CMS data shows 680 Medicare services from Dr. Mehrotra across 5 procedure codes in 2024, for 136 Medicare patients. Medicare paid $67,784 for them.

CMS counts 136 Medicare patients who saw Dr. Mehrotra in 2024. The largest group is under 65, with 81 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 5.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehrotra's median patient age at 59, with 37% women.

In 2024, Dr. Mehrotra wrote 3,012 Medicare Part D claims for 195 patients. 94% of them were for generic drugs. CMS names the drug for 2,751 of them, across 42 drugs with 11 or more claims each, at $191,832 in total drug cost. In 2023, CMS named 1,930 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Mehrotra for performance year 2024, reported as part of a group. Dr. Mehrotra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehrotra as offering telehealth.

Dmand AI links 19 papers to Dr. Mehrotra, published from 2011 to 2019. 2014 was the busiest year, with 5. The most frequent topics are Graft Rejection, Kidney Transplantation and Pilot Projects. Dr. Mehrotra has published most often in Syst Rev. Dr. Mehrotra's most frequent co-authors are Enver Akalin, MD, Scott A. Ames, MD and John Cijiang He, MD.

CMS Open Payments shows 102 general payments to Dr. Mehrotra from 20 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Relypsa, Inc. paid the most, $742.

Dr. Mehrotra graduated from Jefferson Medical College of Thomas Jefferson University in 2004.